Highlights d Serpinb1a and Serpinb6a prevent cathepsin G-dependent neutrophil death d Cathepsin G cleaves gasdermin D at Leu 274 to generate a p30 fragment d Serpin deficiency leads to high inflammation via cathepsin G and gasdermin D d Gasdermin D does not regulate neutrophil death in serpin deficiency In Brief Burgener et al. show that cytosolic protease inhibitors Serpinb1a and Serpinb6a inhibit the granule serine protease cathepsin G to prevent neutrophil and monocyte death and cytokine release upon LPS challenge. Mechanistically, activation of gasdermin D by cathepsin G is required for inflammation but not for neutrophil death.
INTRODUCTION
Regulated forms of cell death are essential for the development of multicellular organisms and for their immune responses. Apoptosis, the most studied form of regulated cell death (RCD), is triggered by intrinsic or extrinsic cues transmitted to signaling routes converging on the proteolytic activation of executioner caspases. These apoptotic caspases cleave multiple protein targets in the nucleus, the cytoplasm, and the cytoskeleton but do not directly compromise the integrity of the plasma membrane (Taylor et al., 2008) . Apoptosis therefore proceeds slowly and without alarming neighboring cells; indeed, the removal of apoptotic bodies by phagocytes induces the release of anti-inflammatory signals (Ravichandran, 2011) . Until recently, RCD was synonymous with apoptosis, but it is now recognized that RCD may also involve necrosis resulting from distinct molecular pathways that have been principally defined as necroptosis and pyroptosis (Bliss-Moreau et al., 2017; Wallach et al., 2016) . Such pathways may have evolved to trigger inflammation in response to potentially concealed infections and cytosolic microbes (Jorgensen et al., 2017; Miao et al., 2010) . Necroptosis occurs in many cell types and can be triggered by tumor necrosis factor-a (TNF-a) as well as other stimuli converging on receptor-interacting protein kinase-3 (RIPK3) (Cho et al., 2009; He et al., 2009; Zhang et al., 2009) , which phosphorylates the pseudo-kinase mixed-lineage kinase-like protein (MLKL). Phosphorylated MLKL oligomerizes, leading to cell death (Murphy et al., 2013) . Pyroptosis has been principally described in monocytes and macrophages and is elicited by inflammatory caspases, caspase-1/4/5/11 (Miao et al., 2010) . This form of RCD is molecularly defined by the specific, limited cleavage of gasdermin D (GSDMD) to release its N-terminal domain GSDMD-p30 (He et al., 2015; Kayagaki et al., 2015; Shi et al., 2015) . GSDMD-p30 assembles to form pores at the plasma membrane leading to cell lysis (Aglietti et al., 2016; Ding et al., 2016; Liu et al., 2016) .
Neutrophils are major effectors of the immune response to infection and drive inflammatory reactions. Neutrophil serine proteases (NSPs) (e.g., neutrophil elastase [NE] , cathepsin G [CatG], proteinase-3 [PR3], and NSP4) contribute to these functions in multiple ways. NSPs are found in specialized secretory lysosomes that fuse with phagosomes or are released into the extracellular milieu upon degranulation. NSPs have antimicrobial functions through defined proteolysis of microbial toxins and structural proteins (Belaaouaj et al., 2000; Tkalcevic et al., 2000; Weinrauch et al., 2002) . Importantly, NSPs promote inflammation through cleavage-mediated activation or inhibition of cytokines, chemokines, opsonins, and receptors (Clancy et al., 2018; Henry et al., 2016; Kessenbrock et al., 2008; Lefranç ais et al., 2012; Padrines et al., 1994; Raptis et al., 2005) . NSPs have been associated with neutrophil death, but the mechanisms are not fully elucidated and appear different for each NSP (Benarafa and Simon, 2017) . Most notably, heterozygous mutations in the gene for NE, ELANE, are the most common cause of severe congenital neutropenia and the only known cause of cyclic neutropenia (Makaryan et al., 2015) . NE is expressed at high levels at the promyelocyte stage and mutant proteins induce cell death and an apparent maturation block at the promyelocyte stage. How the various NE mutants induce cell death is not defined, but it may be due to the unfolded protein response or to mislocalized mutant NE because NE proteolytic activity is not required (Tidwell et al., 2014) . By contrast, CatG and PR3 can directly activate apoptotic pro-caspase-7 and pro-caspase-3, respectively (Loison et al., 2014; Zhou and Salvesen, 1997) . NSPs are also expressed in a subset of monocytes (Kargi et al., 1990) . Recent evidence suggests that NSP-expressing monocytes derive from a neutrophil-like common ancestor (Yanez et al., 2017) , but the function of NSPs in monocyte homeostasis is unknown.
Secreted endogenous inhibitors regulate the activity of NSPs in plasma (e.g., a1-antitrypsin) and mucosal surfaces (e.g., secretory leukocyte protease inhibitor [SLPI] ). Inhibitors of the clade B serpin family are cytosolic and expressed in monocytes and neutrophils (Remold-O'Donnell et al., 1989; Scott et al., 1999) . Among the latter, Serpinb1 is found at high levels in the cytosol of neutrophils and monocytes and inhibits all NSPs except NSP4 Cooley et al., 2001; Perera et al., 2012) . Mice deficient in the mouse ortholog Serpinb1a (Sb1a À/À ) have reduced neutrophil numbers, show increased mortality, and produce high levels of inflammatory cytokines upon lung infection (Benarafa et al., 2007 Gong et al., 2011) . Serpinb6 is a related clade B serpin, also expressed in monocytes and neutrophils, which inhibits CatG but not NE or PR3 (Scott et al., 1999) . Notably, deficiency in the mouse ortholog, Serpinb6a (Sb6a À/À ), was not associated with defects in leukocyte numbers, possibly because Serpinb1a levels are higher in these animals (Scarff et al., 2004) . In this study, we first investigated the effects of combined deficiency of Sb1a and Sb6a (Sb1a.Sb6a À/À ) on leukocyte homeostasis and the effect on RCD pathways of monocytes and neutrophils in vitro. We discovered that the two serpins collaborate to protect myeloid cells through blockade of cell-specific, CatG-dependent RCD. We found that CatG efficiently cleaves GSDMD to generate GSDMD-p30, but deletion of GSDMD did not rescue CatG-mediated neutrophil death in vivo and in vitro. In contrast, we demonstrated that Sb1a.Sb6a À/À mice released more IL-1b, TNF-a, and IL-6 in a CatG-and GSDMD-dependent manner in in vivo models of inflammation and following classical inflammasome activation in macrophages in vitro.
RESULTS

Serpinb1a and Serpinb6a Are Survival Factors for Neutrophils In Vivo
To address the function of Sb1a and Sb6a in myeloid cell homeostasis, we analyzed the leukocyte subsets from single-and double-deficient 6-week-old mice in steady state. Sb1a.Sb6a À/À mice showed a severe reduction in absolute numbers and proportion of neutrophils in the bone marrow (Figures 1A, S1A, and S1B). The neutropenia of Sb1a.Sb6a À/À mice was more severe than that observed in Sb1a À/À mice; and Sb6a À/À mice had normal proportions and numbers of neutrophils ( Figure S1B ; Benarafa et al., 2011; Scarff et al., 2004) . Neutrophil counts in blood were significantly reduced only in Sb1a.Sb6a À/À mice compared to wild-type (WT) mice ( Figure S1C ). Sb1a and Sb6a are both inhibitors of CatG (Benarafa et al., 2002; Scott et al., 1999) , and CatG deletion rescues the neutropenia of Sb1a À/À mice (Baumann et al., 2013) . Thus, we generated mice lacking both serpins and CatG and found that deletion of CatG was indeed sufficient to restore normal neutrophil numbers in bone marrow and blood in steady state (Figures 1A and S1C) .
Neutrophils are rapidly mobilized from the bone marrow in response to infection and have a high phagocytic capacity. To evaluate the relevance of the neutropenia of Sb1a.Sb6a À/À mice on neutrophil recruitment and efficient clearance of fungal particles, we injected opsonized zymosan intraperitoneally. We observed a reduced number of peritoneal neutrophils in Sb1a.Sb6a À/À mice 4 h after zymosan injection ( Figure 1B ). Furthermore, the removal of zymosan was impaired as extracellular particles were still visible in cytospins of peritoneal washes of Sb1a.Sb6a À/À mice, there were higher numbers of neutrophils containing yeast particles, and more zymosan per phagocyte was observed compared to WT mice ( Figure 1C ). Defective neutrophil recruitment and impaired clearance of zymosan particles were fully rescued in CatG.Sb1a.Sb6a À/À mice ( Figures 1B  and 1C ). Thus, control of CatG by Sb1a and Sb6a is crucial to maintain neutrophil survival in steady state and to support efficient innate immune responses.
Apoptotic and Necrotic Pathways in Neutrophils Are Accelerated by CatG Loss of granule membrane integrity can result in the cytosolic release of proteases, which trigger RCD pathways unless opposed by endogenous protease inhibitors (Baumann et al., 2013; Bird et al., 1998 Bird et al., , 2014 Luke et al., 2007) . Cell death of bone marrow neutrophils was therefore evaluated in vitro following treatment with the lysosomotropic compound Lleucyl-L-leucine-methyl-ester (LLME), which is assembled in membranolytic metabolites by the transferase activity of the cysteine protease dipeptidyl-peptidase I (DPPI) to release granule contents into the cytosol (Thiele and Lipsky, 1990) . Reflecting the in vivo phenotype, Sb1a.Sb6a À/À neutrophils were highly sensitive to LLME-induced cell death (Figures 2A and  S2A ). Sb1a.Sb6a À/À neutrophils died significantly faster than Sb1a À/À neutrophils (1 h) after LLME treatment, and few neutrophils remained alive after 2 and 4 h in both genotypes. Sb6a À/À neutrophils showed an intermediate phenotype between Sb1a À/À and WT neutrophils ( Figure S2B ). Live-cell microscopy recordings of bone marrow cells treated with LLME indicated that Sb1a À/À and Sb1a.Sb6a À/À cells initiate an accelerated death process measurable 30 min after LLME treatment ( Figures  S2C and S2D ). LLME-induced cell death was not significantly altered by treatment with the broad caspase inhibitor Q-VD-OPh alone or in combination with the RIPK1 inhibitor necrostatin-1 ( Figure S2B ). In contrast, LLME-induced cell death was fully prevented in CatG.Sb1a.Sb6a À/À neutrophils, where CatG.Sb1a.Sb6a À/À neutrophils exhibited significantly improved survival compared to Sb1a.Sb6a À/À (Figures 2A and S2E ).
Neutrophils have a limited life span in vitro due to spontaneous apoptosis mediated principally by the intrinsic mitochondrial apoptotic pathway culminating with activation of apoptotic caspase-3 and -7 (Geering and Simon, 2011) . Apoptotic neutrophils then rapidly proceed to secondary necrosis. Cultured Sb1a.Sb6a À/À neutrophils showed increased necrosis in the presence of the caspase inhibitor ( Figures 2B  and S3A ). This defect was dependent on CatG since CatG.Sb1a.Sb6a À/À neutrophil spontaneous death in vitro was indistinguishable from that of WT neutrophils. Percentages of apoptotic cells, measured by annexin V staining, were not significantly different between cells of different genotypes ( Figures 2B and S3A ).
Neutrophils are sensitive to death receptor stimulation, which leads to apoptosis or necroptosis depending on caspase-8 activity and X-linked inhibitor of apoptosis (XIAP) (Wang et al., 2018; Wicki et al., 2016) . Neutrophils were stimulated with TNF-a for 24 and 48 h leading to a massive induction of cell death that was indistinguishable between genotypes. Caspase inhibition with Q-VD-OPh considerably reduced TNF-induced neutrophil death in all genotypes. Yet Sb1a.Sb6a À/À neutrophils showed increased necrosis and reduced apoptosis in a CatGdependent manner ( Figures 2C and S3B ). Necroptosis induced by TNF-a depends on the interaction of RIPK1 and RIPK3, which is allowed by RIPK1 autophosphorylation (Cho et al., 2009 ). Inhibition of RIPK1 with necrostatin-1 in presence of Q-VD-OPh reduced neutrophil necrosis in all genotypes but did not abrogate the increased necrosis observed in Sb1a.Sb6a À/À neutrophils ( Figures 2C and S3B ).
Reactive oxygen species (ROS) produced by the NADPHoxidase contribute to neutrophil death in inflammatory conditions (von Gunten et al., 2005) . To explore the role of ROS, we evaluated leukocyte subsets of mice lacking the critical p47phox subunit of the NADPH oxidase (Huang et al., 2000) . We found that both Ncf1.Sb1a À/À and Sb1a À/À mice presented similarly reduced neutrophil numbers in the bone marrow compared to WT and Ncf1. À/À mice in steady state (Figures S3C and S3D) . Granzymes and caspases can induce ROS-mediated cell death by cleaving mitochondrial complex I subunit NDUFS1 (Martinvalet et al., 2008) . Scavenging of mitochondrial ROS with MitoQ did not significantly alter LLME-induced and TNF-induced neutrophil death ( Figures S3E and S3F ). We found that CatG did not cleave the respiratory chain components NDUFS1 and NDUFS3 in Sb1a.Sb6a À/À neutrophils ( Figure S3G ). Overall, these data indicate that Sb1a and Sb6a inhibit CatGmediated apoptotic and necrotic death induced by multiple stimuli such as survival factor withdrawal, death receptor stimulation, and loss of granule integrity. Yet neutrophil death was partly Figure S1 and Tables S1 and S2. blocked by caspase inhibition and was independent of RIPK1 and ROS.
Compensatory Effects of Sb1a and Sb6a in Monocyte Survival
Beyond neutrophils, Sb1a.Sb6a À/À mice presented significantly reduced monocyte numbers and percentage in bone marrow ( Figures S1A and S4A ). The monocyte defect was largely resolved in the bone marrow of CatG.Sb1a.Sb6a À/À mice, which showed monocyte numbers and percentage similar to WT and significantly higher percentage than Sb1a.Sb6a À/À mice. Sb1a À/À and Sb6a À/À single-knockout mice had normal monocyte numbers and percentage in bone marrow, as previously reported (Benarafa, 2011; Scarff et al., 2004 ) ( Figure S4A ). Differences in blood monocytes were variable and showed a subtle downward trend for Sb6a À/À and Sb1a.Sb6a À/À mice (Figure S4B) . No difference between the genotypes was observed in other major blood leukocyte subsets and erythrocytes (Tables S1 and S2). Monocytes were generally less sensitive to LLME than neutrophils, and only Sb1a.Sb6a À/À monocytes showed a significant increase in necrotic cell death following LLME treatment compared to WT ( Figures S4C and S4D ). Cell death in Sb1a À/À and Sb6a À/À monocytes treated with LLME were at intermediate levels between WT and Sb1a.Sb6a À/À ( Figure S4D ). In Sb1a.Sb6a À/À mice, deletion of CatG only partly corrected the accelerated monocyte death after LLME treatment ( Figure S4E ). As in neutrophils, the in vivo and in vitro findings suggest that Sb1a and Sb6a additively, although modestly, contribute to monocyte survival.
CatG Directly Cleaves GSDMD into a Stable N-Terminal Domain GSDMD-p30
Because CatG induces a regulated form of necrosis with fast kinetics, we hypothesized that CatG might process GSDMD to induce cell lysis. We indeed found that purified human CatG cleaved both human and mouse GSDMD to form a stable characteristic GSMD-p30 fragment virtually indistinguishable from that generated by recombinant mouse caspase-11 ( Figures 3A, 3B, S5A, and S5B ). Under the conditions used, purified human NE and PR3 failed to produce a stable GSDMD-p30 fragment at low nanomolar concentrations and had a largely degrading activity on human and mouse GSDMD at higher concentrations ( Figures 3C, 3D , S5C, and S5D). Pretreatment of the proteases with the caspase inhibitor Q-VD-OPh blocked the cleavage of GSDMD by caspase-11 but not by CatG, ruling out indirect activation of caspases in THP-1 and transfected HEK cell lysates ( Figure S5A ). Conversely, CatG inhibitor I (CatG-Inh) had no effect on caspase-11 activity, while effectively inhibiting CatG (Figures S5A-S5D ). We found that cleavage of mouse GSDMD by high concentrations of NE was inhibited by CatG-Inh, suggesting that the observed cleavage may not be caused by NE but by residual CatG activity in the purified preparation of NE from human sputum ( Figure S5C ).
Purified recombinant mouse GSDMD with a C-terminal His-tag (rGSDMD) and active site titrated CatG were used to determine the second order rate constant for CatG cleavage of GSDMD ( Figure S5E ). The k cat /K M value was 1.09 3 10 6 M À1 ,s À1 , which is one or two order of magnitude greater than what we previously reported for caspase-1 (<10 5 M À1 ,s À1 ) and caspase-11 (<10 4 M À1 ,s À1 ), respectively (Gonzalez Ramirez et al., 2018) . The p20 C-terminal fragment generated by CatG was excised and subjected to Edman degradation to reveal that CatG cleaved GSDMD at Leu-274 ( Figures S5E and S5F ). Substitution of Leu-274 for Ala (L274A) or for Gly (L274G) substantially reduced the cleavage of GSDMD by CatG ( Figure S5G ). Incomplete abrogation of CatG cleavage of the L274 mutants suggests that alternative, less preferred, cleavage sites for CatG may exist in the linker region between the N-and C-terminal regions when high protease concentrations are used ( Figure S5F ). Together, these findings demonstrate that GSDMD is a preferred substrate of CatG, which cleaves GSDMD only two residues upstream of the caspase cleavage site at Asp-276 (Kayagaki et al., 2015; Shi et al., 2015) .
Sb1a.Sb6a À/À Neutropenia Is Not Due to Pyroptosis Mediated by GSDMD We then ruled out a role for pyroptotic caspases in the steadystate neutropenia due to Sb1a deficiency. Deletion of both mouse inflammatory caspases (Casp1 and Casp11) did not rescue the bone marrow neutropenia in Casp1/11.Sb1a À/À mice (Figures S6A and S6B) . Furthermore, we observed no difference in cell death kinetics after granule permeabilization of Casp1/11.Sb1a À/À neutrophils compared to Sb1a À/À neutrophils treated with LLME ( Figure S6C ). To address whether Gsdmd is required for neutrophil death in vivo, we generated Gsdmd knockout mice by CRISPR/Cas9 targeting in Sb1a.Sb6a À/À zygotes. Five mutant alleles were identified, and each was bred to homozygosity ( Figure S7 ). We found that Gsdmd.Sb1a.Sb6a À/À had reduced neutrophils in the bone marrow similarly as Sb1a.Sb6a À/À mice, while Gsdmd À/À neutrophil numbers were the same as in WT mice in steady state ( Figure 4A ). Furthermore, granule permeabilization with LLME induced identical kinetics of necrosis in Gsdmd.Sb1a.Sb6a À/À as in Sb1a.Sb6a À/À neutrophils ( Figures 4B and S8A) . Likewise, spontaneous apoptosis was not altered in neutrophils lacking Gsdmd in WT or Sb1a.Sb6a À/À backgrounds ( Figures 4C and  S8B ). We also found that TNF-mediated death pathways were consistently increased in Gsdmd.Sb1a.Sb6a À/À (as in Sb1a.Sb6a À/À ) compared to Gsdmd À/À and WT neutrophils (Figures 4D and S8C) . Deletion of Gsdmd appears to reduce monocyte numbers in the bone marrow compared to WT mice, but no further decrease in monocyte numbers and percentage was observed in Gsdmd.Sb1a.Sb6a À/À compared to Sb1a.Sb6a À/À bone marrow ( Figure S8D ). Moreover, LLME-induced death was similarly enhanced in Gsdmd.Sb1a.Sb6a À/À and Sb1a.Sb6a À/À monocytes, and no difference was observed between WT and Gsdmd À/À monocytes in this assay ( Figure S8E) . Neutrophil and monocyte percentage in blood of Gsdmd À/À and Gsdmd.Sb1a.Sb6a À/À were similar to each other and intermediate between WT and Sb1a.Sb6a À/À ( Figure S8F ). Higher absolute counts of neutrophils in blood in Gsdmd.Sb1a.Sb6a À/À and Gsdmd À/À compared to Sb1a.Sb6a À/À mice does not reflect a specific rescue but is rather due to elevated total white blood counts (WBCs) in Gsdmd À/À and Gsdmd.Sb1a.Sb6a À/À compared to other genotypes ( Figure S8F ; Table S2 ). Overall, our findings demonstrate that Gsdmd is dispensable for the death pathways mediated by CatG and regulated by Sb1a and Sb6a in vivo and in vitro.
Sb1a and Sb6a Regulate Endotoxin-Mediated
Inflammation in a CatG-and GSDMD-Dependent Manner Activation of GSDMD by inflammatory caspases and assembly of GSDMD-p30 at the plasma membrane contribute in part to the release of mature IL-1b and Gsdmd À/À mice are largely protected against endotoxemic shock (Kayagaki et al., 2015; Shi et al., 2015) . Conversely, we have previously shown that Sb1a À/À mice release increased levels of inflammatory cytokines in association with failed clearance of Pseudomonas aeruginosa infection (Benarafa et al., 2007) . To test the physiological relevance of the cleavage of GSDMD by CatG, we measured the early systemic cytokine response to intraperitoneal injection of a sublethal dose of lipopolysaccharide (LPS). We found that Sb1a.Sb6a À/À mice had significantly higher levels of TNF-a at 2 h after injection and increased IL-6 and IL-1 b at 6 h compared to WT mice ( Figure 5A) . Importantly, increased systemic inflammation was dependent on CatG, as cytokine levels in CatG.Sb1a.Sb6a À/À mirrored those of WT mice ( Figure 5A ). As expected, GSDMD was essential for the detection of IL-1b but, importantly, deletion of GSDMD also reduced TNF-a levels (2 h) but not IL-6 levels (6 h) in Gsdmd.Sb1a.Sb6a À/À mice (Figure 5A) . Similarly, in a lung inflammation model induced by intranasal instillation of LPS, Sb1a.Sb6a À/À mice showed a significant increase in TNF-a and IL-6 in bronchoalveolar lavage (BAL) 14 h after instillation, and this increase was dependent on both CatG and GSDMD ( Figure 5B ). At this time point, IL-1b levels in BAL were very low to undetectable in all genotypes.
To evaluate direct effects of the cytosolic serpins on IL-1b release, we finally investigated the effects of canonical inflammasome activation in bone marrow-derived macrophages (BMDMs). We found that IL-1b release by Sb1a.Sb6a À/À BMDMs was significantly higher than by WT primed BMDMs stimulated with nigericin or ATP at 3 and 18 h. Furthermore, this effect was again completely dependent on both CatG and GSDMD ( Figure 5C ). In all conditions, we did not observe any significant difference in cell death (lactate dehydrogenase [LDH] release) between genotypes ( Figure S8G ). Taken together, our data indicate that Sb1a and Sb6a regulate inflammatory responses through the regulation of CatG and in part through prevention of GSDMD processing in macrophages.
DISCUSSION
Serpinb1 and Serpinb6 are ancient clade B serpin genes and are conserved in all vertebrates (Benarafa and Remold-O'Donnell, 2005; Kaiserman and Bird, 2005) . In this study, we found that both mouse orthologs Serpinb1a and Serpinb6a are survival factors of neutrophils and monocytes. In neutrophils, cell death was increased in single serpin knockout mice, and it was significantly more severe in Sb1a.Sb6a À/À neutrophils. In monocytes, each serpin compensated for the absence of the other, and reduced survival of monocytes was observed only in double-knockout Sb1a.Sb6a À/À mice. Both serpins have very fast inhibitory second order rate constants for CatG, 10 7 mol/L À1 ,s À1 for Serpinb6 and 2 3 10 6 mol/L À1 ,s À1 for Serpinb1 (Cooley et al., 2001; Scott et al., 1999) . Since CatG deletion rescues the neutrophil defect of Sb1a À/À neutrophils (Baumann et al., 2013) , we anticipated and demonstrated that CatG is essential in inducing cell death in Sb1a.Sb6a À/À neutrophils in homeostatic conditions in vivo. Moreover, granule permeabilization-induced cell death was reduced in CatG.Sb1a.Sb6a À/À neutrophils, indicating that the CatG/serpin axis is critical in this neutrophil RCD pathway. In monocytes, CatG deletion also rescued monocyte numbers in mice lacking both serpins.
Increased spontaneous death and TNF-induced death of Sb1a.S6a À/À neutrophils in vitro also highlighted the contribution of the two serpins in regulating CatG in these RCD pathways. Spontaneous neutrophil apoptosis is largely driven by the intrinsic apoptotic pathway and can be significantly delayed by sustained expression of anti-apoptotic BCL-2 family proteins such as Mcl-1 and A1 and by apoptotic caspase inhibitors (Akgul et al., 2001) . TNF-a induces apoptosis through the activation of RIPK1, p38 MAPK, PI3K, and generation of ROS by the NADPH oxidase triggering caspase-3 cleavage (Geering and Simon, 2011) . Caspase inhibition shifts the apoptotic pathway to necroptosis (Wallach et al., 2016) . Here, caspase and RIPK1 inhibition improved survival of Sb1a.S6a À/À neutrophils in spontaneous and TNF-induced apoptosis, respectively. Yet Sb1a.S6a À/À neutrophils showed more necrotic cells at late time points in the presence of these inhibitors. Therefore, while apoptotic caspases and RIPK1-RIPK3-MLKL are the principal drivers of these RCD pathways, CatG significantly and independently contributes to the acceleration of the dying process toward necrosis (cell lysis). Indeed, granule/lysosomal permeabilization is a late event during TNF-induced death or after NLRP3 inflammasome activation; and this process is associated with cleavage of mitochondrial complex 1 proteins and triggered or enhanced by mitochondrial ROS (Heid et al., 2013; Huai et al., 2013; Oberle et al., 2010) . In neutrophils, the prime source of ROS is the NADPH oxidase, but we found that deletion of the essential p47phox subunit in Ncf1.Sb1a À/À mice did not rescue neutrophil survival in vivo and in vitro. Furthermore, CatG did not cleave NDUFS1 and NDUFS3, which are essential for the production of ROS by mitochondria and were shown to be proteolytically inactivated by caspases and granzymes to induce apoptosis (Huai et al., 2013; Jacquemin et al., 2015; Martinvalet et al., 2008) . The ROS scavenger MitoQ did not alter cell death mediated by LLME and TNF-a in neutrophils in vitro, indicating that CatG-mediated RCD can largely proceed independently of ROS.
Live-cell imaging experiments demonstrated that LLMEtreated Sb1a À/À and Sb1a.Sb6a À/À neutrophils proceeded rapidly through necrotic death with cell membrane blebbing, swelling, and rupture suggestive of pyroptosis (Liu and Lieberman, 2017) . We found that human CatG directly cleaves human and mouse GSDMD to generate an N-terminal discreet cleavage product. The cleavage site of mouse GSDMD was identified at Leu-274, only two residues upstream of the conserved Asp-276 cleaved by caspase-1/11. This is reminiscent of the activation of caspase-7 by CatG, which is also two residues upstream of the canonical Asp site (Zhou and Salvesen, 1997) . Furthermore, the kinetics of cleavage indicates that GSDMD is a preferred substrate of CatG. A recent study reported that excess recombinant NE cleaved GSDMD and that this cleavage of GSDMD induced neutrophil death. They also reported that Gsdmd À/À mice were less effective in clearing intraperitoneally injected E. coli (Kambara et al., 2018) . In our hands, human purified NE did not cleave either human or mouse GSDMD into a stable GSDMD-p30 fragment. CatG inhibitor I inhibited the cleavage of GSDMD with high NE concentrations, indicating the presence of residual CatG in the purified NE preparation. Furthermore, we found that deletion of caspase-1/11 and, more critically, deletion of GSDMD had no effect on the neutropenia of Sb1a À/À and Sb1a.Sb6a À/À mice. In addition, caspase-1/11 and GSDMD did not directly contribute to cell death induced by granule permeabilization. We previously showed that NE-deficient neutrophils were equally sensitive to granule permeabilization-induced death as WT neutrophils (Baumann et al., 2013) . Serpinb1a also inhibits PR3 (Benarafa et al., 2002) , which was shown to activate caspase-3 leading spontaneous apoptosis (Loison et al., 2014) . We have shown here that PR3 can cleave GSDMD but generates several fragments that are rapidly degraded, and therefore PR3 may disarm GSDMD-dependent pyroptosis. Release of PR3 together with CatG may in part explain why GSDMD is not involved in cell death in neutrophils. Alternatively, similarly to caspase-3, CatG may have multiple target proteins leading to cell death in addition to caspase-7 and GSDMD and only combined disruption of multiple pathways may restore neutrophil survival in the absence of Serpinb1 and Serpinb6.
Importantly, our study revealed that cytosolic serpins regulate inflammatory cytokine responses and this effect was dependent on CatG and GSDMD. We found increased IL-1b release from Sb1a.Sb6a À/À activated macrophages and high levels of IL-6 and TNF-a following local and systemic injection of LPS. The increased cytokine levels in vitro and in vivo were all dependent on CatG and GSDMD, suggesting that the serpins likely regulate release of this inflammatory cytokine in part through inhibition of processing of GSDMD by CatG. Higher levels of IL-1b and danger signals released from necrotic cells in Sb1a.Sb6a À/À mice may in turn lead to the sustained production of TNF-a and IL-6. IL-1b is produced in the cytosol as a biologically inactive pro-form that is activated by cleavage of an N-terminal propeptide. NSPs can process several pro-forms of the IL-1 family members, including IL-1b, IL-33, IL-36a, IL-36b, and Il-36g (Clancy et al., 2018; Hazuda et al., 1990; Henry et al., 2016; Lefranç ais et al., 2012; Macleod et al., 2016) . While inflammatory caspases have a predominant role in IL-1b processing in activated myeloid cells, NSPs substantially contribute to enhancing the responses in vivo (Adkison et al., 2002; Kono et al., 2012) . NSPs are thought to contribute to inflammation in part through processing of IL-1 family members after they are released from necrotic cells as unprocessed pro-forms. Indeed, the reported cleavage sites by NSPs on IL-1 cytokines are located N-terminally of the Asp residues cleaved by caspases. Our study suggests an additional pathway where CatG promotes the release of IL-1b cells via GSDMD activation. Thus, more pro-IL-1b may be processed and released by activated myeloid cells when cytosolic serpins are downregulated or overwhelmed by proteases leading to enhanced release via GSDMD processing by CatG. This may explain in part previous observations of increased release of IL-1b in lungs of Sb1a À/À mice infected with Pseudomonas aeruginosa or influenza A virus (Benarafa et al., 2007; Gong et al., 2011) . Whether this process is occurring with other IL-1 family cytokines and in other cells than macrophages is currently under study. As we were resubmitting this revised manuscript, a study reported a non-covalent interaction between C-terminal domain of Serpinb1 and the CARD domain of inflammatory caspases that was proposed to prevent spontaneous caspase activation (Choi et al., 2019) . They show that Sb1a À/À mice are more susceptible to a lethal dose of LPS and to bacterial infection. These data are in agreement with our current data and our previous studies showing that clearance of P. aeruginosa is reduced in Sb1a À/À mice. However, we have also shown that clearance of P. aeruginosa can be rescued by increasing neutrophil numbers following enhanced myelopoiesis with granulocyte-colony stimulating factor (G-CSF) treatment (Basilico et al., 2016) . In contrast to the recent report by Choi et al. (2019) , we did not observe increased spontaneous release of IL-1b when macrophages were incubated with LPS for 5 h in absence of nigericin or ATP ( Figure S8H ). Thus, without contradicting a potential direct interaction between caspases and Sb1a shown by these authors, our data presented here demonstrate a more conventional and straightforward mechanism dependent on CatG inhibition by Serpinb1a and Serpinb6a leading to inflammation via GSDMD processing.
In summary, our findings indicate that Serpinb1a and Serpinb6a are key survival factors in neutrophils and monocytes. They protect neutrophils from multiple death pathways through inhibition of CatG, which activates both executors of apoptosis and of pyroptosis: caspase-7 and GSDMD, respectively. Yet our data indicate that CatG does not rely exclusively on any of the known RCD pathways. By contrast, GSDMD is a critical target of CatG-mediated death of monocytes in steady state in vivo but not after granule permeabilization. Finally, we demonstrate that Serpinb1a and Serpinb6a critically regulate IL-1b release and systemic inflammation by regulating myeloid cell necrosis and an alternative activation of GSDMD.
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